Medpace (MEDP)
(Delayed Data from NSDQ)
$397.56 USD
-9.59 (-2.36%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $398.06 +0.50 (0.13%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth A Momentum A VGM
Medpace (MEDP) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$379.20 | $480.00 | $273.00 | -6.86% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Medpace comes to $379.20. The forecasts range from a low of $273.00 to a high of $480.00. The average price target represents a decline of 6.86% from the last closing price of $407.15.
Analyst Price Targets (5 )
Broker Rating
Medpace currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 4 | 4 | 4 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 2 | 2 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.67 | 1.67 | 1.40 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/14/2024 | Robert W. Baird & Co. | Eric W Coldwell | Strong Buy | Strong Buy |
10/30/2023 | William Blair | Maxwell A Smock | Strong Buy | Strong Buy |
9/18/2023 | Guggenheim Securities | Jack D Wallace | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 6 |
Average Target Price | $379.20 |
LT Growth Rate | 18.00% |
Industry | Medical Services |
Industry Rank by ABR | 91 of 252 |
Current Quarter EPS Est: | 2.53 |